Sublocade · DIN 02483092 · 300 mg/1.5 mL · injection solution- 1.5mL pre-filled syringe
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Sublocade · DIN 02483092
Manufacturer: Indivior UK Limited; listing date 2020-04-30
Health Canada: Marketed since 2020-02-03 · brand SUBLOCADE · ATC N07BC01 BUPRENORPHINE · form Solution (extended-release) · route Subcutaneous · ingredients BUPRENORPHINE 300 MG/1.5ML · company Indivior uk limited · schedule Narcotics (cdsa i)
Sublocade: Formulary list price $550.00 per unit (the source does not state the unit; exact figure $550.0000). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02483092)
Source record
DIN 02483092: Sublocade
Raw flags: sec3=Y
Item: 280812025; group id 414; item number 1020; lccId None; manufacturer id IND
Source form: Inj Sol- 1.5mL Pref Syr; strength: 300mg/1.5mL
Recorded listing: General benefit
Source prices (unrounded): $550.0000; ministry $550.0000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02483092
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97349
Shortage status: not checked (no credentials)